SCHEMBL18200569

SCHEMBL18200569

c1ccc(-c2nc(-c3ccccn3)nc(-c3ccc(-c4nc5ccccc5c5c4ccc4ccccc45)c4ncccc34)n2)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 4/20 0.43
TDP1 Q9NUW8 4/20 0.41
KDM4E B2RXH2 3/20 0.41
RAB9A P51151 5/20 0.40
KMT2A Q03164 5/20 0.40
L3MBTL1 Q9Y468 4/20 0.40
MAPK1 P28482 3/20 0.40
LMNA P02545 2/20 0.40
TSHR P16473 2/20 0.40
MAPT P10636 5/20 0.40
ALDH1A1 P00352 3/20 0.40
POLB P06746 1/20 0.40
MEN1 O00255 3/20 0.39
NPC1 O15118 4/20 0.38
TP53 P04637 2/20 0.38
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
HSD17B10 Q99714 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200567 0.91 TOP2A (0.40) TDP1KDM4ERAB9AKMT2AL3MBTL1
SCHEMBL18200835 0.90 LMNA (0.37) TDP1KDM4ERAB9AKMT2AMAPK1
SCHEMBL18201160 0.89 CYP1A2 (0.43) TDP1KDM4ERAB9AL3MBTL1MAPK1
SCHEMBL18200873 0.89 CYP3A4 (0.40) TDP1KDM4EMAPK1LMNATSHR
SCHEMBL18200833 0.88 TOP1 (0.46) KDM4EL3MBTL1MAPK1TSHRMAPT
SCHEMBL18201251 0.88 TOP2A (0.40) TDP1KDM4ERAB9AKMT2AL3MBTL1
SCHEMBL18201150 0.87 MEN1 (0.40) KDM4ERAB9AKMT2AMAPK1LMNA
SCHEMBL18200568 0.86 TOP2A (0.34) TDP1KDM4ELMNATSHRMAPT
SCHEMBL18201152 0.85 COMT (0.41) TDP1KDM4ERAB9AKMT2AL3MBTL1
SCHEMBL18201151 0.85 ALDH1A1 (0.41) TDP1KDM4ERAB9AKMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 METAP1 2608/4885TDP1 2443/4885KDM4E 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.